Do you know about GRIPE? It’s the Group for Research in Pathology Education and it just concluded its winter meeting last week at Marshall University in Huntington, West Virginia. The organization has approximately 120 subscribers and, although most are located in the United States, it does have subscribers in countries ranging from Grenada and Ireland to New Guinea and India. GRIPE’s mission is to “advance the quality of pathology education through scholarly research” and related activities. For more information about GRIPE, visit the organization’s URL: http://peir.path.uab.edu/griper/.
BRITAIN’S NATIONAL HEALTH SERVICE TO RAMP UP HPV TEST PROGRAM
It is a move that the United Kingdom’s National Health Service (NHS) believes will both save money and improve patient outcomes. In England, programs to use HPV testing in cervical cancer screening conducted by general practitioners (GP) will be ramped up during 2011. As reported in the web service PulseToday.co.uk, currently in England, only two hospital laboratories—in Bristol and Manchester—use HPV tests as part of cervical cancer screening services.
ADD TO: HPV Testing
In the United Kingdom at this time, Scotland uses HPV tests only in the follow-up to treatment. Both Northern Ireland and Wales are conducting studies of HPV testing. An NHS spokesman stated that one pilot project involving HPV testing at a sentinel site in northwest London led to an 85% reduction in the number of women requiring consecutive post-treatment cytological surveillance.
- Caris Life Sciences, Inc., of Irving, Texas, announced that Amy Jensen Cunniffe would serve in the newly-created position of Senior Vice President for Government Affairs. Cunniffe will establish a Caris office in Washington, DC. Cunniffe most recently served at GE Healthcare in the role of Leader for the Government Relations Team. Caris’ new office inside the beltway is a sign that the lab testing company expects much government activity in the regulation of healthcare, including molecular and genetic testing.
Dark Daily Update
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about…
…the pending growth in the number of companion diagnotic tests that will reach market in coming years. This prediction is based on development deals between IVD firms and pharma companies.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.